Opendata, web and dolomites

CELLPHASE_AD SIGNED

Genetics to understand cellular components of Alzheimer Disease pathogenesis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CELLPHASE_AD project word cloud

Explore the words cloud of the CELLPHASE_AD project. It provides you a very rough idea of what is the project "CELLPHASE_AD" about.

engineered    context    extensive    dynamic    crisper    population    complexity    patient    generate    hypotheses    humanized    classically    cell    genomic    disease    expression    possibilities    influences    genetic    beta    worldwide    pathology    validate    insights    capture    limitations    genetics    gt    centric    understudied    wild    translation    patients    drug    chimeric    profiles    putative    cas9    ips    manipulate    pathological    versatile    establishes    single    600    neuron    mechanistic    genes    cells    accelerated    view    astroglia    expressed    risk    progression    scores    stem    isogenic    rodent    inflammation    pathogenesis    followed    therapies    mouse    first    cholesterol    mice    human    polygenic    platform    tau    makeup    alzheimer    time    arm    linked    brain    answer    provides    vitro    health    models    microglia    largely    validating    vivo    transplanted    bioinformatics    lines    explore    phenotypes    ad    axis    inducible    transcriptomics   

Project "CELLPHASE_AD" data sheet

The following table provides information about the project.

Coordinator
VIB 

Organization address
address: RIJVISSCHESTRAAT 120
city: ZWIJNAARDE - GENT
postcode: 9052
website: www.vib.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 2˙374˙997 €
 EC max contribution 2˙374˙997 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-ADG
 Funding Scheme ERC-ADG
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2024-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VIB BE (ZWIJNAARDE - GENT) coordinator 2˙374˙997.00

Map

 Project objective

Alzheimer disease (AD) is a major health problem worldwide. New therapies require an accelerated translation of genetic information into mechanistic insights. Given limitations of rodent models, fully humanized models are needed to capture the complexity of the disease process. Human stem cells (iPS) provide great possibilities but are largely investigated in vitro with associated limitations. Many of the novel genetic risk factors for AD are expressed in microglia and astroglia, which remains an understudied population in this classically neuron-centric field. We propose here mouse-human chimeric mouse models to test the effects of AD-associated genetic risk factors on the phenotypes of transplanted microglia and astroglia derived from patients and from genomic engineered, isogenic stem cells. The cells will be followed during disease progression in brain of wild type and of mice developing Aβ- and Tau- pathology. Using single cell transcriptomics, a dynamic view of the cell states over time is generated. In a first arm of the project, we investigate how the genetic makeup of patient derived stem cells with high and low polygenic risk scores influences pathological cell states. In the second arm of the project, we generate inducible Crisper/CAS9 iPS isogenic cell lines to manipulate rapidly and specifically the expression of 4 selected AD associated genes linked to a putative cholesterol pathway but also affecting inflammation. These cell lines will be used also in the second phase of the project when validating hypotheses generated from the extensive bioinformatics analysis of the 600.000 single human cell profiles generated. We expect to identify and validate >5 novel drug targets in the astroglia-microglia axis of AD pathogenesis. Our work provides humanized models for AD, an answer on how genetic makeup affects microglia and astroglia in an AD relevant context, and establishes a highly versatile platform to explore human genetics in human cells in vivo.

 Publications

year authors and title journal last update
List of publications.
2019 Renzo Mancuso, Johanna Van Den Daele, Nicola Fattorelli, Leen Wolfs, Sriram Balusu, Oliver Burton, Adrian Liston, Annerieke Sierksma, Yannick Fourne, Suresh Poovathingal, Amaia Arranz-Mendiguren, Carlo Sala Frigerio, Christel Claes, Lutgarde Serneels, Tom Theys, V. Hugh Perry, Catherine Verfaillie, Mark Fiers, Bart De Strooper
Stem-cell-derived human microglia transplanted in mouse brain to study human disease
published pages: 2111-2116, ISSN: 1097-6256, DOI: 10.1038/s41593-019-0525-x
Nature Neuroscience 22/12 2019-12-16

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CELLPHASE_AD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CELLPHASE_AD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

CoolNanoDrop (2019)

Self-Emulsification Route to NanoEmulsions by Cooling of Industrially Relevant Compounds

Read More  

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More  

QUAMAP (2019)

Quasiconformal Methods in Analysis and Applications

Read More